Abstract
Peptide-based vaccine delivery can be hampered by rapid peptidase activity and poor inherent immunogenicity. The self-adjuvanting lipid core peptide system (LCP) has been shown to confer improved stability and immunogenicity on peptide epitopes of group A Streptococcus, Chlamydia, hookworm, and malaria pathogens. However, various diseases, including cancer, still require targeted delivery of their vaccine candidates. For this reason, we have selected two model peptides (ovalbumin CD4(+) and/or CD8(+) T cell epitopes), and incorporated two or four copies of either epitope into our LCP vaccine. Optimised glycosylation of ovalbumin peptides yielded 46 % when microwave-assisted double coupling with 2 eq of carbohydrate derivative, activated by N,N-diisopropylethylamine and (O-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate, was performed. All ovalbumin peptides were successfully synthesised and purified in 11-55 % yields by Fmoc- or Boc-chemistry using solid-phase peptide synthesis. The mannosylated ovalbumin peptides were nontoxic to human erythrocytes in haemolytic assay (<2 % haemolysis) and showed increased (up to 20-fold) stability in plasma.
References
Feb 7, 1998·Journal of Pharmaceutical Sciences·B DrouillatI Toth
Apr 2, 1998·Journal of Pharmaceutical Sciences·M NomotoM Hayashi
Jun 3, 2000·Annual Review of Immunology·J BanchereauK Palucka
Jun 20, 2003·Nature Reviews. Drug Discovery·Brian L Bray
Nov 25, 2003·European Journal of Immunology·Christine Bourgeois, Corinne Tanchot
Dec 2, 2004·Expert Opinion on Biological Therapy·Tibor KelerMichael W Fanger
Jun 29, 2005·Molecular Pharmaceutics·Benjamin P RossIstvan Toth
Jul 20, 2005·Carbohydrate Research·Mian LiuDavid Live
Apr 28, 2006·Journal of Pharmaceutical Sciences·Ketan Amin, Rose-Marie Dannenfelser
Aug 19, 2006·Medical Microbiology and Immunology·Thomas BickertKlaus J Erb
Apr 5, 2007·Organic & Biomolecular Chemistry·Jonathan M Collins, Nicholas E Leadbeater
Apr 28, 2007·Science·Sven BurgdorfChristian Kurts
Aug 21, 2007·Journal of Medicinal Chemistry·Peter M MoyleIstvan Toth
Mar 8, 2008·Advanced Drug Delivery Reviews·Laura J PeekCory Berkland
Apr 3, 2008·Biopolymers·Pavla SimerskaIstvan Toth
May 13, 2008·Bioorganic & Medicinal Chemistry·Yasuko KodaJoanne T Blanchfield
Jun 6, 2008·Expert Opinion on Drug Delivery·Juan M IracheSocorro Espuelas
Apr 22, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrea L Szymczak-WorkmanDario A A Vignali
Sep 25, 2009·Immunology·Karen S M PhillippsIstvan Toth
Dec 23, 2009·Medicinal Research Reviews·Pavla SimerskaIstvan Toth
Jan 30, 2010·Clinical Therapeutics·Michael Steinberg
Feb 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Craig D PlattLélia Delamarre
May 27, 2010·Scandinavian Journal of Immunology·L-Z SunK Vaali
Aug 18, 2010·Vaccine·Geert Leroux-Roels
Jun 12, 2012·Journal of Medicinal Chemistry·Pegah VaraminiIstvan Toth
Jul 27, 2012·Current Medicinal Chemistry·D GoodwinI Toth
Sep 1, 2012·PloS One·Simon H ApteDenise L Doolan
Oct 12, 2012·PloS One·Mariusz SkwarczynskiIstvan Toth
Dec 12, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·L J Thomann-HarwoodK C McCullough
Feb 5, 2013·Biomaterials·Eiji YubaKenji Kono